Examkin

Soru

Zorluk: OrtaMedical History Evaluation

A 68-year-old man is brought to the emergency department due to a 2-day history of severe, generalized muscle pain, profound weakness, and dark-colored urine. His past medical history is significant for type 2 diabetes mellitus, essential hypertension, hyperlipidemia, and a laparoscopic cholecystectomy ten years ago. He does not use tobacco, alcohol, or illicit drugs. His chronic medications include metformin, lisinopril, and simvastatin. He has been fully adherent to this exact medication regimen for the past five years without any adverse effects. Vital signs are temperature 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure 135/85135/85 mmHg, pulse 8888/min, and respirations 1616/min. Physical examination reveals diffuse muscle tenderness, particularly in the proximal thighs and shoulders, with normal neurological reflexes. Initial laboratory studies show a serum creatine kinase level of 8,5008,500 U/L and a serum creatinine of 1.91.9 mg/dL (baseline 0.90.9 mg/dL). During the interview, the patient casually mentions that he visited an urgent care clinic five days ago for acute sinusitis and was given a new prescription. Eliciting a detailed history regarding which of the following is most essential for identifying the precipitant of this patient's current condition?

  1. A
    Intentional or accidental doubling of the simvastatin dosage
  2. B
    Use of over-the-counter sympathomimetic decongestants
  3. Recent initiation of a macrolide antibioticCevap
  4. D
    Concomitant use of high-dose nonsteroidal anti-inflammatory drugs
  5. E
    Recent administration of preventive respiratory vaccinations

Cevap

Recent initiation of a macrolide antibiotic is the critical historical element to establish the etiology.
The patient is presenting with classic signs of acute rhabdomyolysis (severe myalgias, weakness, dark urine, and markedly elevated creatine kinase). He has been stable on simvastatin for five years. The abrupt onset of severe statin toxicity immediately following an urgent care visit for a respiratory infection points to a classic pharmacokinetic drug-drug interaction. Simvastatin is extensively metabolized by the cytochrome P450 3A4 (CYP3A4) isoenzyme in the liver and intestines. Macrolide antibiotics, such as clarithromycin and erythromycin, are potent inhibitors of CYP3A4. Co-administration drastically reduces the clearance of simvastatin, leading to toxic serum concentrations that precipitate severe myopathy and rhabdomyolysis. Therefore, explicitly asking the patient if he was prescribed a macrolide antibiotic is the most critical next step in evaluating his medical history to confirm the etiology.

Adım Adım Çözüm

1
Identify the patient's primary clinical syndrome from the clinical presentation and laboratory results.
The patient has acute rhabdomyolysis, evidenced by severe muscle pain, weakness, dark urine (myoglobinuria), and a profoundly elevated creatine kinase level (8,5008,500 U/L) complicated by acute kidney injury.
Establishing the current clinical syndrome is necessary to narrow down the differential diagnosis.
2
Review the patient's chronic medication list and medical history for potential underlying causes.
The patient has been taking simvastatin for five years. Statins are a known cause of myopathy and rhabdomyolysis, but he has been stable on this dose for years without adverse effects.
Identifying chronic risk factors highlights vulnerabilities, but a stable regimen requires a new precipitating event to cause acute toxicity.
3
Analyze the new historical information (the urgent care visit for acute sinusitis) for a precipitating factor.
The patient was prescribed a new medication for sinusitis five days ago. The most critical step is determining if this new drug interacts with his chronic medications.
Drug-drug interactions are a leading cause of acute statin toxicity.
4
Correlate standard treatments for sinusitis with the metabolic pathways of the patient's chronic medications.
Macrolide antibiotics (like clarithromycin) are sometimes prescribed for sinusitis and are potent inhibitors of the CYP3A4 enzyme, which metabolizes simvastatin. This interaction leads to toxic statin accumulation and subsequent rhabdomyolysis.
Understanding pharmacokinetic pathways explains the sudden onset of the adverse event.

Anahtar Kavram

Identifying critical drug-drug interactions through meticulous medication history taking, specifically recognizing that CYP3A4 inhibitors (e.g., macrolide antibiotics) can precipitate acute rhabdomyolysis in patients stable on CYP3A4-metabolized statins.
Bu soruyu puanla

Konular

Medical History Evaluation

Bu konudan daha fazla soru